Active Ingredient: Pravastatin
Reduction of post transplantation hyperlipidaemia in-patient receiving immunosuppressive therapy following solid organ transplantation.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
20 - 40 mg
From 20 To 40 mg once every day
Following organ transplantation a starting dose of 20 mg per day is recommended in patients receiving immunosuppressive therapy. Depending on the response of the lipid parameters, the dose may be adjusted up to 40 mg under close medical supervision.
Pravastatin sodium is administered orally once daily preferably in the evening with or without food.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
